(Q39979979)

English

mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

object named as

Yasushi Yatabe

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Junichi Shimizu

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Yoshitsugu Horio

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hirotaka Osada

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Toyoaki Hida

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Yoshinori Hasegawa

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Kaoru Shimokata

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Takashi Takahashi

7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Yoshitaka Sekido

8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

510-517

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Targeted therapy in combination with gemcitabine in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Single-agent gemcitabine in patients with resistant small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

A gene expression database for the molecular pharmacology of cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2008.01302.X

21 January 2018

Identifiers

10.1111/J.1440-1843.2008.01302.X

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39979979&oldid=1980906258"